Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer

This study has been completed.
Information provided by:
CASI Pharmaceuticals, Inc. Identifier:
First received: December 5, 2006
Last updated: January 19, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)